Use of 38 % silver diamine fluoride as a cariostatic therapy
Keywords:
Silver diamine fluoride; dental caries; cariostatic therapy; preventive dentistry; public healthAbstract
The 38 % silver diamine fluoride (SDF) has gained popularity in dentistry for its ability to halt dental caries, especially in vulnerable populations and resource-limited settings. However, its use is limited by aesthetic concerns due to the black staining it causes on treated teeth. The objective of the study was to interpret the use of 38 % silver diamine fluoride as a cariostatic therapy through a literature review. A systematic search was conducted in PubMed to identify relevant studies published in the last five years. The results indicate that SDF is highly effective in halting the progression of dental caries compared to other treatments like dental sealants and shows a favorable safety profile. However, dental staining remains a significant barrier to its acceptance, and the stability of the SDF solution is another challenge that limits its long-term clinical application. Additionally, the study highlights the importance of patient education to improve treatment acceptance. Despite these challenges, SDF presents itself as a valuable tool in the fight against dental caries, especially in low-resource settings. In conclusion, while SDF offers an effective and accessible solution for caries management, future research should focus on improving its formulation and evaluating its acceptance in various cultural and socioeconomic contexts to maximize its impact on global dental health.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish in this journal agree to the following terms: Authors retain copyright and grant the journal the right of first publication, with the work simultaneously licensed under the Creative Commons Attribution-NonCommercial License (CC BY-NC 4.0), which allows others to share the work provided that its authorship and initial publication in this journal are acknowledged. Authors may enter into separate, additional agreements for the non-exclusive distribution of the published version of the work (e.g., posting it to an institutional repository or publishing it in a book), provided that its initial publication in this journal is acknowledged. Authors are permitted and encouraged to share their work online (e.g., in institutional repositories or on their personal website) before and during the submission process, as this can lead to productive exchanges and increase citation of the published work (see The Effect of Open Access).
As the Revista Cubana de Investigaciones Biomédicas is part of the SciELO network, once articles have been accepted into the editorial process (peer review), authors may, if they agree, deposit them in SciELO Preprints and update them there once the review process and layout proofs are complete.
